Literature DB >> 19483715

Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats.

Ying Zhou1, Xiang-Qian Xiao, Lin-Feng Chen, Rui Yang, Jian-Dang Shi, Xiao-Ling Du, Helmut Klocker, Irwin Park, Chung Lee, Ju Zhang.   

Abstract

It is known that human benign prostatic hyperplasia might arise from an estrogen/androgen (E/T) imbalance. We studied the response of castrated rat prostate to different ratios of circulating E/T. The castrated male Wistar rats were randomly injected with E/T at different ratios for 4 weeks. The prostates of E/T (1:100) group showed a distinct prostatic hyperplasia response by prostatic index, hematoxylin and eosin staining, and quantitative immunohistochemical analysis of alpha-smooth muscle actin (SMA). In this group, cells positive for Vimentin, non-muscle myosin heavy chain (NMMHC) and proliferating cell nuclear antigen (PCNA) increased in the stroma and epithelium. Furthermore, the mRNA levels of smooth muscle myosin heavy chain (SMMHC) and NMMHC increased. So E/T at a ratio of 1:100 can induce a stromal hyperplastic response in the prostate of castrated rats. The main change observed was an increase of smooth muscle cells, whereas some epithelial changes were also seen in the rat prostates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19483715      PMCID: PMC3735307          DOI: 10.1038/aja.2009.28

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  36 in total

Review 1.  Molecular mechanisms of phenotypic plasticity in smooth muscle cells.

Authors:  A J Halayko; J Solway
Journal:  J Appl Physiol (1985)       Date:  2001-01

Review 2.  Estrogen in the etiopathogenesis of BPH.

Authors:  W E Farnsworth
Journal:  Prostate       Date:  1999-12-01       Impact factor: 4.104

Review 3.  Origin and differentiation of human and murine stroma.

Authors:  James E Dennis; Pierre Charbord
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

4.  Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins.

Authors:  N F Worth; B E Rolfe; J Song; G R Campbell
Journal:  Cell Motil Cytoskeleton       Date:  2001-07

5.  17beta-estradiol affects proliferation and apoptosis of rat prostatic smooth muscle cells by modulating cell cycle transition and related proteins.

Authors:  Yi Luo; Wafi Waladali; Shiwen Li; Xinmin Zheng; Liquan Hu; Hang Zheng; Wanli Hu; Chan Chen
Journal:  Cell Biol Int       Date:  2008-04-08       Impact factor: 3.612

6.  Homeobox protein Hex induces SMemb/nonmuscle myosin heavy chain-B gene expression through the cAMP-responsive element.

Authors:  K Sekiguchi; M Kurabayashi; Y Oyama; Y Aihara; T Tanaka; H Sakamoto; Y Hoshino; T Kanda; T Yokoyama; Y Shimomura; H Iijima; Y Ohyama; R Nagai
Journal:  Circ Res       Date:  2001-01-19       Impact factor: 17.367

7.  Evidence that estrogens directly alter androgen-regulated prostate development.

Authors:  R A Jarred; B Cancilla; G S Prins; K A Thayer; G R Cunha; G P Risbridger
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

8.  Androgen and prostatic stroma.

Authors:  Yuan-Jie Niu; Teng-Xiang Ma; Ju Zhang; Yong Xu; Rui-Fa Han; Guang Sun
Journal:  Asian J Androl       Date:  2003-03       Impact factor: 3.285

9.  Identification of genes involved in estrogenic action in the human prostate using microarray analysis.

Authors:  Jasmin Bektic; Oliver A Wrulich; Gabriele Dobler; Kurt Kofler; Florian Ueberall; Zoran Culig; Georg Bartsch; Helmut Klocker
Journal:  Genomics       Date:  2004-01       Impact factor: 5.736

10.  Characteristic pattern of human prostatic growth with age.

Authors:  Shu-Jie Xia; Xiao-Xin Xu; Jian-Bao Teng; Chun-Xiao Xu; Xiao-Da Tang
Journal:  Asian J Androl       Date:  2002-12       Impact factor: 3.285

View more
  8 in total

1.  Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

Authors:  Rui Yang; Yu-Xia Ma; Lin-Feng Chen; Ying Zhou; Zhan-Po Yang; Yan Zhu; Xiao-Ling Du; Jian-Dang Shi; Hong-Shun Ma; Ju Zhang
Journal:  Asian J Androl       Date:  2010-05-17       Impact factor: 3.285

Review 2.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

3.  Influence of immune inflammation on androgen receptor expression in benign prostatic hyperplasia tissue.

Authors:  Zong-Lin Wu; Ya Yuan; He Geng; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2011-12-12       Impact factor: 3.285

Review 4.  Animal models of benign prostatic hyperplasia.

Authors:  Junjie Zhang; Mengda Zhang; Jin Tang; Guangming Yin; Zhi Long; Leye He; Chuanchi Zhou; Lufeng Luo; Lin Qi; Long Wang
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-09-01       Impact factor: 5.554

5.  Compounds from Cynomorium songaricum with Estrogenic and Androgenic Activities Suppress the Oestrogen/Androgen-Induced BPH Process.

Authors:  Xueni Wang; Rui Tao; Jing Yang; Lin Miao; Yu Wang; Jose Edouard Munyangaju; Nuttapong Wichai; Hong Wang; Yan Zhu; Erwei Liu; Yanxu Chang; Xiumei Gao
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-15       Impact factor: 2.629

6.  Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia.

Authors:  Bo Chen; Dehong Cao; Zeyu Chen; Yin Huang; Tianhai Lin; Jianzhong Ai; Liangren Liu; Qiang Wei
Journal:  Transl Androl Urol       Date:  2020-04

7.  Piperazine-Derived α1D/1A Antagonist 1- Benzyl-N- (3-(4- (2-Methoxyphenyl) Piperazine-1-yl) Propyl) -1H- Indole-2- Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking.

Authors:  Qing Xiao; Qi-Meng Liu; Ru-Chao Jiang; Kai-Feng Chen; Xiang Zhu; Lei Ma; Wei-Xi Li; Fei He; Jun-Jun Huang
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

8.  Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS).

Authors:  Tyler Greer; Ling Hao; Anatoliy Nechyporenko; Sanghee Lee; Chad M Vezina; Will A Ricke; Paul C Marker; Dale E Bjorling; Wade Bushman; Lingjun Li
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.